4.6 Review

CTLA4 gene polymorphism and autoimmunity

Journal

IMMUNOLOGICAL REVIEWS
Volume 204, Issue -, Pages 102-115

Publisher

WILEY
DOI: 10.1111/j.0105-2896.2005.00249.x

Keywords

-

Categories

Funding

  1. Wellcome Trust [075021] Funding Source: Medline

Ask authors/readers for more resources

CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA4) are two receptors that have critical but opposing functions in T-cell stimulation. CD28 promotes a number of T-cell activities, whereas in contrast CTLA4 is an essential inhibitor of T-cell responses. Because of its inhibitory role, CTLA4 is a strong candidate susceptibility gene in autoimmunity and several studies suggest disease-associated polymorphisms. In this review, we discuss recent progress in relating CTLA4 polymorphisms to disease susceptibility and consider the putative mechanisms by which CTLA4 may act to inhibit autoimmunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available